Literature DB >> 12705780

Societal effects of hearing aid fitting among the moderately hearing impaired.

Manuela A Joore1, Danielle E M Brunenberg, Michelene N Chenault, Lucien J C Anteunis.   

Abstract

The objective of this study was to evaluate hearing aid fitting from a societal viewpoint, rather than the more traditional patient perspective. The effects of hearing aid fitting on generic quality of life (EuroQol), social functioning (SF36), auditory disability, productivity at paid and unpaid labour, and medical consumption, were assessed in a prospective study among 80 moderately hearing-impaired first-time hearing aid applicants. The study showed that hearing aid fitting solved problems with paid employment, but did not seem to affect unpaid work. Use of medical services remained relatively stable after first-time hearing aid fitting. The Amsterdam Inventory proved to be a useful questionnaire to assess the effects on hearing disability. No effects of hearing aid fitting on generic quality of life could be determined with the EuroQol, while hearing aid fitting did lead to an improvement in one aspect of generic quality of life; namely social functioning.

Entities:  

Mesh:

Year:  2003        PMID: 12705780     DOI: 10.3109/14992020309090424

Source DB:  PubMed          Journal:  Int J Audiol        ISSN: 1499-2027            Impact factor:   2.117


  17 in total

Review 1.  Health-related quality of life and hearing aids: a tutorial.

Authors:  Harvey B Abrams; Theresa H Chisolm; Rachel McArdle
Journal:  Trends Amplif       Date:  2005

2.  The WHO-DAS II: psychometric properties in the measurement of functional health status in adults with acquired hearing loss.

Authors:  Theresa H Chisolm; Harvey B Abrams; Rachel McArdle; Richard H Wilson; Patrick J Doyle
Journal:  Trends Amplif       Date:  2005

3.  Counselling of hearing aid users is highly cost-effective.

Authors:  Arja Vuorialho; Petri Karinen; Martti Sorri
Journal:  Eur Arch Otorhinolaryngol       Date:  2006-06-24       Impact factor: 2.503

Review 4.  Comparative studies on hearing aid selection and fitting procedures: a review of the literature.

Authors:  Mick Metselaar; Bert Maat; Hans Verschuure; Wouter A Dreschler; Louw Feenstra
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-10-23       Impact factor: 2.503

Review 5.  MarkeTrak 10 (MT10) Survey Results Demonstrate High Satisfaction with and Benefits from Hearing Aids.

Authors:  Erin M Picou
Journal:  Semin Hear       Date:  2020-02-10

6.  Quality of life after intervention with a cochlear implant or hearing aid.

Authors:  Kevin J Contrera; Joshua Betz; Lingsheng Li; Caitlin R Blake; Yoon K Sung; Janet S Choi; Frank R Lin
Journal:  Laryngoscope       Date:  2016-01-17       Impact factor: 3.325

Review 7.  Suggested response criteria for phase II antitumor drug studies for neurofibromatosis type 2 related vestibular schwannoma.

Authors:  Scott R Plotkin; Chris Halpin; Jaishri O Blakeley; William H Slattery; D Bradley Welling; Susan M Chang; Jay S Loeffler; Gordon J Harris; A Gregory Sorensen; Michael J McKenna; Fred G Barker
Journal:  J Neurooncol       Date:  2009-05-09       Impact factor: 4.130

8.  Self-reported disability and handicap after hearing-aid fitting and benefit of hearing aids: comparison of fitting procedures, degree of hearing loss, experience with hearing aids and uni- and bilateral fittings.

Authors:  Mick Metselaar; Bert Maat; Pieta Krijnen; Hans Verschuure; Wouter A Dreschler; Louw Feenstra
Journal:  Eur Arch Otorhinolaryngol       Date:  2008-11-13       Impact factor: 2.503

Review 9.  Hearing difficulties, ear-related diagnoses and sickness absence or disability pension--a systematic literature review.

Authors:  Emilie Friberg; Klas Gustafsson; Kristina Alexanderson
Journal:  BMC Public Health       Date:  2012-09-12       Impact factor: 3.295

Review 10.  The impact of hearing loss on the quality of life of elderly adults.

Authors:  Andrea Ciorba; Chiara Bianchini; Stefano Pelucchi; Antonio Pastore
Journal:  Clin Interv Aging       Date:  2012-06-15       Impact factor: 4.458

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.